Paul Tudor Jones’s BELLUS Health Inc. BLU Stock Holding History

Paul Tudor Jones’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,662	Closed	-$260K	–	2981
2022 Q3	$260K	Buy	+24,662	New	+$262K	0.01%	1889

Other funds holding BLU

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Power Corp of Canada Montreal, Quebec, Canada $843M AUM 39.5% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Paul Tudor Jones's BLU Position: Q4 2022 in Review

Paul Tudor Jones sold out of BELLUS Health Inc. (BLU) in Q4 2022, closing a stake of 24,662 shares — an estimated $260K sold.

Paul Tudor Jones first reported a position in BLU in Q3 2022 and held it in 1 quarter. The position peaked at $260K in Q3 2022. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

Paul Tudor Jones reported no remaining BELLUS Health Inc. position as of Q4 2022 after selling out during the quarter.
Paul Tudor Jones sold 24,662 BELLUS Health Inc. shares in Q4 2022, an estimated $260K.
Paul Tudor Jones first reported a position in BELLUS Health Inc. in Q3 2022 and held it in 1 quarter.
Paul Tudor Jones's BELLUS Health Inc. position peaked at $260K in Q3 2022.
121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.